Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1997;30:345-350

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, D. H.
Right arrow Articles by Du, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, D. H.
Right arrow Articles by Du, Y.

(Hypertension. 1997;30:345.)
© 1997 American Heart Association, Inc.


Articles

Regulation of Type 1 Angiotensin II Receptor in Adrenal Gland

Role of {alpha}1-Adrenoreceptor

Donna H. Wang; Jingxin Qiu; Zhaoyong Hu; Yong Du

From the Department of Internal Medicine, Hypertension and Vascular Research Laboratories, University of Texas Medical Branch (Galveston).

Correspondence to Donna H. Wang, MD, Department of Internal Medicine, Hypertension and Vascular Research Laboratories, 8.104 Medical Research Bldg, University of Texas Medical Branch, Galveston, TX 77555-1065. E-mail dwang{at}utmb.edu

Abstract We have previously shown that sodium restriction upregulates the genes encoding angiotensin II receptor (AT1) subtypes, AT1A and AT1B, in the adrenal gland and that this upregulation is mediated by activation of the AT1 receptor. There are multiple interactions between the renin-angiotensin and the adrenergic nervous systems; thus, we conducted the present experiment to investigate whether low sodium-induced upregulation of adrenal AT1A and AT1B is modulated by the {alpha}1-adrenoreceptor. Seven-week-old male Wistar rats were divided into four groups and given normal sodium diet (0.5%, NS), NS+prazosin (3.5 µg · kg-1 · min- 1 by osmotic pump), low sodium diet (0.07%, LS), or LS+prazosin. Body weight and mean arterial pressure were not modified over the 2 weeks of treatment (P>.05). Pressor responses to bolus injection of the {alpha}1-agonist phenylephrine were inhibited in both prazosin groups, compared with NS and LS rats (P<.05). Adrenal AT1A mRNA, determined by Northern blot analysis, was increased in LS (P<.05) but not in NS+prazosin (P>.05), compared with NS. Prazosin enhanced the LS-induced increase of AT1A mRNA (P<.05). Adrenal AT1B mRNA was increased in both LS and NS+prasozin rats, compared with NS rats (P<.05). Prazosin also enhanced the LS-induced increase in AT1B mRNA (P<.05). Therefore, blockade of {alpha}1-adrenoreceptor results in an enhancement of LS-induced upregulation of adrenal mRNA for AT1A and AT1B. These data suggest that the sympathetic nervous system exerts an inhibitory action, via activation of the {alpha}1-adrenoreceptor, on AT1A and AT1B gene expression in the adrenal gland during sodium depletion.


Key Words: receptors, angiotensin • receptors, adrenergic, alpha • adrenal glands • sodium, dietary




This article has been cited by other articles:


Home page
EndocrinologyHome page
R. Kouyama, T. Suganami, J. Nishida, M. Tanaka, T. Toyoda, M. Kiso, T. Chiwata, Y. Miyamoto, Y. Yoshimasa, A. Fukamizu, et al.
Attenuation of Diet-Induced Weight Gain and Adiposity through Increased Energy Expenditure in Mice Lacking Angiotensin II Type 1a Receptor
Endocrinology, August 1, 2005; 146(8): 3481 - 3489.
[Abstract] [Full Text] [PDF]